Skip to main content
. 2017 Feb 14;37(4):1989–1997. doi: 10.3892/or.2017.5443

Figure 2.

Figure 2.

ERCC1 silencing increased cisplatin sensitivity of XWLC05 cell line in vitro. (A) Quantitative analysis of apoptotic cells under the treatment of cisplatin (1 µM) in ERCC1 silencing cell line and its controls (P<0.05). Error bar 95% Confidence intervals (Cis). (B) The proliferous capacity of XWLC05 ERCC1-shRNA cell line and its control with or without the treatment of cisplatin (1 µM) by CCK8 kit (P<0.05). Error bars 95% CIs. (C and D) Detection of colony formation ability of XWLC05 ERCC1-shRNA cell line and its control with or without the treatment of cisplatin (1 µM) and quantitative analysis of colony formation (P<0.05). Error bars 95% CIs.